NFLs Rooney Rule Faces Legal Challenges Amid Broader DEI Policy Shifts Bessent Forecasts Substantial Disinflation Under Incoming Fed Chair Warsh Should You Sell Aka Brands AKA After 1229 Drop 20260515 Should You Sell Bowman BWMN After 523 Drop 20260515 How Indias SIP Culture Could Be Indirectly Weighing on the Rupee Jefferies Analysis NetApp NTAP Surges 418 as Storage Demand Outlook Brightens What PureCycle PCTTWs 466 Decline Means for Investors 20260520 HR Block HRB Q1 2026 Earnings Surprise EPS 602 Up Significant Spotify Shares Surge on AI Music Partnership with UMG and Upbeat Guidance ICON plc Schedules Q4 and FY2025 Earnings Call Discloses Nasdaq Deficiency Notice Feds Williams Signals Current Rate Policy Appropriate Amid Economic Outlook Yen Stalls as Japanese Retail Investors Stay on Sidelines Amid Market Uncertainty Indian Commerce Minister Piyush Goyal to Lead 150Member Business Delegation to Canada to Strengthen Trade Ties RBI Approves ICICI Bank CEO Sandeep Bakhshis Reappointment for Two More Years Investors Title Company Q4 2025 Earnings Strong Profitability Amid Flat Revenue Trends Redwood Trust Inc 900 Senior Notes Due 2029 RWTO Q1 2026 Earnings EPS Miss Weighs on Note Performance Mexco Energy Corporation MXC Q3 2025 Earnings EPS of 022 Highlights Profitability Stock Rises CapsoVision CV Q1 2026 Earnings EPS Miss Raises Concerns Amid Operational Uncertainty SPWH Q1 2026 Earnings Narrow EPS Miss Leaves Stock Flat Evaxion Q1 2026 Earnings EPS Miss Weighs on PreRevenue Biotech Stock Edges Higher MetaVia Inc MTVA Tumbles 2286 as Selling Pressure Intensifies Below Critical Threshold Defi Technologies Inc DEFT Sees Modest Decline Amid Broader Crypto Sector Volatility OXLCN Preferred Stock Holds Steady Near Par as Market Digests Interest Rate Outlook Domo Inc DOMO Rallies 2 as Stock Approaches Key Resistance Tapestry Inc Holds Steady Near 139 as Traders Eye Key Levels Consumer Prices Rise 38 in April Marking Highest Annual Inflation Since May 2023 BTGO Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter Enliven Therapeutics ELVN Faces Pressure as Shares Dip 168 Key Support Levels in Focus